Back to top

Top Ranked Growth Stocks to Buy for April 12th

Read MoreHide Full Article

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, April 12th:

John Bean Technologies Corporation (JBT - Free Report) : This food processing and air transportation company, which carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings rising 3.7% over the last 60 days.

John Bean Technologies has a PEG ratio 1.74, compared with 1.83 for the industry. The company possesses a Growth Score of A.

Dycom Industries, Inc. (DY - Free Report) : This specialty contracting services, which carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.2% over the last 60 days.

Dycom Industries has a PEG ratio 1.25, compared with 1.62 for the industry. The company possesses a Growth Score of A.

Mettler-Toledo International Inc. (MTD - Free Report) : This manufacturer and supplier of precision services, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings rising 0.1% over the last 60 days.

Mettler-Toledo International has a PEG ratio 2.37, compared with 2.41 for the industry. The company possesses a Growth Score of A.

Evercore Partners Inc. (EVR - Free Report) : This investment banking advisory firm, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.8% over the last 60 days.

Evercore Partners has a PEG ratio 1.33, compared with 1.45 for the industry. The company possesses a Growth Score of A.

See the full list of top ranked stocks here

Learn more about the Growth score and how it is calculated here

5 Trades Could Profit "Big-League" from Trump Policies

If the stocks above spark your interest, wait until you look into companies primed to make substantial gains from Washington's changing course.

Today Zacks reveals 5 tickers that could benefit from new trends like streamlined drug approvals, tariffs, lower taxes, higher interest rates, and spending surges in defense and infrastructure. See these buy recommendations now >>



More from Zacks Zacks #1 Rank Additions

You May Like